{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:40:31Z","timestamp":1793418031730,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2019M3E5D1A02068142"],"award-info":[{"award-number":["2019M3E5D1A02068142"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There are still controversies regarding the treatment and outcomes in culture-negative pyogenic vertebral osteomyelitis (PVO). The purpose of this study is to investigate the antimicrobial therapy, assessment of therapeutic response, and outcome of culture-negative PVO compared to culture-positive PVO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study was performed with non-surgical lumbar PVO patients. The patients were divided into two groups based on the causative bacterial identification (CN group with culture-negative PVO and CP group with culture-positive PVO). The clinical features, use of antibiotics, laboratory data, and outcomes were compared between the two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seventy-three patients with 41 (56.2%) of the CN group and 32 (43.8%) of the CP group were enrolled. The CN group showed a shorter duration of parenteral antibiotics (45.88\u2009\u00b1\u200916.14 vs. 57.31\u2009\u00b1\u200924.39,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.019) but a tendency of prolonged duration of total (parenteral + oral) antibiotics (101.17\u2009\u00b1\u200952.84 vs. 84.19\u2009\u00b1\u200950.29\u2009days,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.168). When parenteral antibiotics were discontinued or switched to oral antibiotics, the mean erythrocyte segmentation rate (ESR, normal range: &lt;\u200925\u2009mm\/h), C-reactive protein (CRP, normal range: &lt;\u20090.5\u2009mg\/dL) level, and visual analog scale (VAS) score of back pain were 42.86\u2009\u00b1\u200924.05\u2009mm\/h, 0.91\u2009\u00b1\u20091.18\u2009mg\/dL, and 4.05\u2009\u00b1\u20091.07, respectively, with no significant differences between the two groups. The recurrence rates of CN and CP groups were 7.3% (3\/41) and 6.3% (2\/32), respectively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20091.000). The presence of epidural abscess was the most significant factor for the identification of causative bacteria (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), and there was no significant relationship between the use of empirical antibiotics before tissue culture and the causative bacterial identification (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.194).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The CN group required a shorter duration of parenteral antibiotics than the CP group. Discontinuation of parenteral antibiotics or changing the administration route can be considered based on the values of ESR, CRP, and VAS score of back pain. The presence of epidural abscess was the most significant factor for the identification of causative bacteria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05669-1","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T08:21:59Z","timestamp":1607502119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Antimicrobial therapy and assessing therapeutic response in culture-negative pyogenic vertebral osteomyelitis: a retrospective comparative study with culture-positive pyogenic vertebral osteomyelitis"],"prefix":"10.1186","volume":"20","author":[{"given":"Dongwoo","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1293-2724","authenticated-orcid":false,"given":"Ikchan","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"issue":"12","key":"5669_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/ard.56.12.709","volume":"56","author":"JD Colmenero","year":"1997","unstructured":"Colmenero JD, Jimenez-Mejias ME, Sanchez-Lora FJ, Reguera JM, Palomino-Nicas J, Martos F, Garcia de las Heras J, Pachon J. Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases. Ann Rheum Dis. 1997;56(12):709\u201315.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5669_CR2","doi-asserted-by":"publisher","first-page":"E102","DOI":"10.1097\/BSD.0000000000000597","volume":"31","author":"K Issa","year":"2018","unstructured":"Issa K, Diebo BG, Faloon M, Naziri Q, Pourtaheri S, Paulino CB, Emami A. The epidemiology of vertebral osteomyelitis in the United States from 1998 to 2013. Clin Spine Surg. 2018;31(2):E102\u20138.","journal-title":"Clin Spine Surg"},{"issue":"23","key":"5669_CR3","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1097\/01.brs.0000244662.78725.37","volume":"31","author":"JS Butler","year":"2006","unstructured":"Butler JS, Shelly MJ, Timlin M, Powderly WG, O'Byrne JM. Nontuberculous pyogenic spinal infection in adults: a 12-year experience from a tertiary referral center. Spine (Phila Pa 1976). 2006;31(23):2695\u2013700.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"2","key":"5669_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0090-3019(01)00681-4","volume":"57","author":"JA Friedman","year":"2002","unstructured":"Friedman JA, Maher CO, Quast LM, McClelland RL, Ebersold MJ. Spontaneous disc space infections in adults. Surg Neurol. 2002;57(2):81\u20136.","journal-title":"Surg Neurol"},{"issue":"10","key":"5669_CR5","first-page":"181","volume":"105","author":"R Sobottke","year":"2008","unstructured":"Sobottke R, Seifert H, Fatkenheuer G, Schmidt M, Gossmann A, Eysel P. Current diagnosis and treatment of spondylodiscitis. Dtsch Arztebl Int. 2008;105(10):181\u20137.","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"5669_CR6","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1093\/cid\/civ482","volume":"61","author":"EF Berbari","year":"2015","unstructured":"Berbari EF, Kanj SS, Kowalski TJ, Darouiche RO, Widmer AF, Schmitt SK, Hendershot EF, Holtom PD, Huddleston PM 3rd, Petermann GW, et al. 2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis. 2015;61(6):e26\u201346.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"5669_CR7","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMcp0910753","volume":"362","author":"W Zimmerli","year":"2010","unstructured":"Zimmerli W. Clinical practice. Vertebral osteomyelitis. N Engl J Med. 2010;362(11):1022\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"5669_CR8","first-page":"42","volume":"69","author":"KH Park","year":"2014","unstructured":"Park KH, Cho OH, Jung M, Suk KS, Lee JH, Park JS, Ryu KN, Kim SH, Lee SO, Choi SH, et al. Clinical characteristics and outcomes of hematogenous vertebral osteomyelitis caused by gram-negative bacteria. J Inf Secur. 2014;69(1):42\u201350.","journal-title":"J Inf Secur"},{"key":"5669_CR9","doi-asserted-by":"crossref","unstructured":"Jeon I, Kong E, Yu D, Hong CP. Clinical and radiological analysis of pyogenic vertebral osteomyelitis immediately after successful antimicrobial therapy: considerations for assessing therapeutic response. Diagnostics. 2020;10(11).","DOI":"10.3390\/diagnostics10110861"},{"issue":"10","key":"5669_CR10","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/cid\/ciw098","volume":"62","author":"KH Park","year":"2016","unstructured":"Park KH, Cho OH, Lee JH, Park JS, Ryu KN, Park SY, Lee YM, Chong YP, Kim SH, Lee SO, et al. Optimal duration of antibiotic therapy in patients with Hematogenous vertebral osteomyelitis at low risk and high risk of recurrence. Clin Infect Dis. 2016;62(10):1262\u20139.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"5669_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.semarthrit.2011.04.002","volume":"41","author":"J Lora-Tamayo","year":"2011","unstructured":"Lora-Tamayo J, Euba G, Narvaez JA, Murillo O, Verdaguer R, Sobrino B, Narvaez J, Nolla JM, Ariza J. Changing trends in the epidemiology of pyogenic vertebral osteomyelitis: the impact of cases with no microbiologic diagnosis. Semin Arthritis Rheum. 2011;41(2):247\u201355.","journal-title":"Semin Arthritis Rheum"},{"key":"5669_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ijid.2019.10.010","volume":"89","author":"A Russo","year":"2019","unstructured":"Russo A, Graziano E, Carnelutti A, Sponza M, Cadeo B, Sartor A, Righi E, Bassetti M. Management of vertebral osteomyelitis over an eight-year period: the UDIPROVE (UDIne PROtocol on VErtebral osteomyelitis). Int J Infect Dis. 2019;89:116\u201321.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"5669_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/02688690701546155","volume":"21","author":"S Bhagat","year":"2007","unstructured":"Bhagat S, Mathieson C, Jandhyala R, Johnston R. Spondylodiscitis (disc space infection) associated with negative microbiological tests: comparison of outcome of suspected disc space infections to documented non-tuberculous pyogenic discitis. Br J Neurosurg. 2007;21(5):473\u20137.","journal-title":"Br J Neurosurg"},{"issue":"3","key":"5669_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10067-008-1051-5","volume":"28","author":"EM de Lucas","year":"2009","unstructured":"de Lucas EM, Gonzalez Mandly A, Gutierrez A, Pellon R, Martin-Cuesta L, Izquierdo J, Sanchez E, Ruiz E, Quintana F. CT-guided fine-needle aspiration in vertebral osteomyelitis: true usefulness of a common practice. Clin Rheumatol. 2009;28(3):315\u201320.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"5669_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ijid.2006.02.011","volume":"10","author":"A Hassoun","year":"2006","unstructured":"Hassoun A, Taur Y, Singer C. Evaluation of thin needle aspiration biopsy in the diagnosis and management of vertebral osteomyelitis (VO). Int J Infect Dis. 2006;10(6):486\u20137.","journal-title":"Int J Infect Dis"},{"issue":"7","key":"5669_CR16","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/cid\/cir062","volume":"52","author":"J Marschall","year":"2011","unstructured":"Marschall J, Bhavan KP, Olsen MA, Fraser VJ, Wright NM, Warren DK. The impact of prebiopsy antibiotics on pathogen recovery in hematogenous vertebral osteomyelitis. Clin Infect Dis. 2011;52(7):867\u201372.","journal-title":"Clin Infect Dis"},{"issue":"948","key":"5669_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/pgmj.2003.017863","volume":"80","author":"JJ Rankine","year":"2004","unstructured":"Rankine JJ, Barron DA, Robinson P, Millner PA, Dickson RA. Therapeutic impact of percutaneous spinal biopsy in spinal infection. Postgrad Med J. 2004;80(948):607\u20139.","journal-title":"Postgrad Med J"},{"issue":"2","key":"5669_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.semarthrit.2014.04.008","volume":"44","author":"J Kim","year":"2014","unstructured":"Kim J, Kim YS, Peck KR, Kim ES, Cho SY, Ha YE, Kang CI, Chung DR, Song JH. Outcome of culture-negative pyogenic vertebral osteomyelitis: comparison with microbiologically confirmed pyogenic vertebral osteomyelitis. Semin Arthritis Rheum. 2014;44(2):246\u201352.","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"5669_CR19","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1086\/340102","volume":"34","author":"MC McHenry","year":"2002","unstructured":"McHenry MC, Easley KA, Locker GA. Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleveland-area hospitals. Clin Infect Dis. 2002;34(10):1342\u201350.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"5669_CR20","first-page":"iii11","volume":"65","author":"T Gouliouris","year":"2010","unstructured":"Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother. 2010;65(Suppl 3):iii11\u201324.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"5669_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00264-011-1425-1","volume":"36","author":"K Zarghooni","year":"2012","unstructured":"Zarghooni K, Rollinghoff M, Sobottke R, Eysel P. Treatment of spondylodiscitis. Int Orthop. 2012;36(2):405\u201311.","journal-title":"Int Orthop"},{"issue":"9971","key":"5669_CR22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(14)61233-2","volume":"385","author":"L Bernard","year":"2015","unstructured":"Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, Le Moing V, Belmatoug N, Lesprit P, Bru JP, et al. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet. 2015;385(9971):875\u201382.","journal-title":"Lancet"},{"issue":"9971","key":"5669_CR23","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S0140-6736(14)61936-X","volume":"385","author":"J Lora-Tamayo","year":"2015","unstructured":"Lora-Tamayo J, Murillo O. Shorter treatments for vertebral osteomyelitis. Lancet. 2015;385(9971):836\u20137.","journal-title":"Lancet"},{"issue":"5","key":"5669_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.semarthrit.2006.09.004","volume":"36","author":"F Roblot","year":"2007","unstructured":"Roblot F, Besnier JM, Juhel L, Vidal C, Ragot S, Bastides F, Le Moal G, Godet C, Mulleman D, Azais I, et al. Optimal duration of antibiotic therapy in vertebral osteomyelitis. Semin Arthritis Rheum. 2007;36(5):269\u201377.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"5669_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jbspin.2006.11.002","volume":"74","author":"F Grados","year":"2007","unstructured":"Grados F, Lescure FX, Senneville E, Flipo RM, Schmit JL, Fardellone P. Suggestions for managing pyogenic (non-tuberculous) discitis in adults. Joint Bone Spine. 2007;74(2):133\u20139.","journal-title":"Joint Bone Spine"},{"key":"5669_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/1471-2334-14-226","volume":"14","author":"B Babouee Flury","year":"2014","unstructured":"Babouee Flury B, Elzi L, Kolbe M, Frei R, Weisser M, Scharen S, Widmer AF, Battegay M. Is switching to an oral antibiotic regimen safe after 2 weeks of intravenous treatment for primary bacterial vertebral osteomyelitis? BMC Infect Dis. 2014;14:226.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05669-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05669-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05669-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T08:24:53Z","timestamp":1607502293000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05669-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5669"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05669-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-42510\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-42510\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-42510\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"12 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants in this study were anonymized. The use of data from the hospital database for the analysis was approved by the institutional review board (Yeungnam University Hospital, 2020-06-091). Written informed consent was waived due to retrospective study design.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"939"}}